Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neupath Health Inc. ( (TSE:NPTH) ) just unveiled an announcement.
NeuPath Health Inc. announced its participation in the Planet MicroCap Showcase: TORONTO 2025, where CEO Joe Walewicz will present the company’s strategies and answer questions. This event offers NeuPath an opportunity to engage with investors and stakeholders, potentially enhancing its visibility and positioning in the healthcare industry.
The most recent analyst rating on (TSE:NPTH) stock is a Buy with a C$0.50 price target. To see the full list of analyst forecasts on Neupath Health Inc. stock, see the TSE:NPTH Stock Forecast page.
More about Neupath Health Inc.
NeuPath Health Inc. operates a network of healthcare clinics in Ontario and Alberta, specializing in chronic pain treatment, musculoskeletal injuries, sports injuries, and concussions. The company also provides workplace health services, independent medical assessments, and contract research services to pharmaceutical and biotechnology companies.
Average Trading Volume: 78,990
Technical Sentiment Signal: Buy
Current Market Cap: C$20.1M
Learn more about NPTH stock on TipRanks’ Stock Analysis page.